FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
7 letters match. Newest first.
-
DrugsTKTX USA
FDA warned TKTX USA that its TKTX Numbing Creams are unapproved and misbranded drugs with lidocaine levels above OTC limits.
High risk -
DrugsTKTX Numb Store
FDA warned TKTX Numb Store that its lidocaine anesthetic creams are unapproved and misbranded drugs sold without a prescription.
High risk -
DrugsCentura Pharmaceuticals Inc
FDA warned Centura Pharmaceuticals that its BLT 1-2-3 Cream, a mixed numbing product for cosmetic procedures, is an unapproved new drug.
High risk -
DrugsDermal Source, Inc.
FDA warned Dermal Source that five topical anesthetic products are unapproved and misbranded drugs with lidocaine above OTC limits.
High risk -
DrugsTKTX Company
TKTX Company sells unapproved, misbranded lidocaine numbing creams online at illegal concentrations for cosmetic procedures.
High risk -
DrugsCetylite Industries, Inc.
FDA warned Cetylite Industries over CGMP violations at its Pennsauken, NJ facility, including unvalidated testing and inadequate OOS investigations for topical anesthetics.
High risk -
DevicesDental Technologies Inc.
FDA warned Dental Technologies Inc. over contaminated Paroex oral rinse and inadequate drug and device manufacturing controls.
High risk